Tocilizumab group:None

2 trials

Sponsors

The First Affiliated Hospital of Wenzhou Medical University, China-Japan Friendship Hospital

Conditions

Antisynthetase syndrome-associated interstitial lung diseaseSystemic Sclerosis

Unknown Phase

Therapeutic Effects of IL-6 Inhibition in Patients with Systemic Sclerosis: A Clinical Observation

Active, not recruitingChiCTR2500097181

The First Affiliated Hospital of Wenzhou Medical UniversitySystemic Sclerosis

Start: 2025-02-13Updated: 2025-02-17

Observational Study on the Efficacy and Safety of Tocilizumab in the Real-World Treatment of Refractory Interstitial Pneumonia Associated with Anti-Synthetase Syndrome

Active, not recruitingChiCTR2600128650

China-Japan Friendship HospitalAntisynthetase syndrome-associated interstitial lung disease

Start: 2026-07-30Updated: 2026-08-03